| Samotolisib studied in …STUDIED_INderived14 of 14show fewer |
|---|
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · 14 trials list this drug (3 active) | — | — | Hepatoblastoma,Malignant Germ Cell Tumor,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632994available Master Rollover Protocol for Continued Safety Assessment of Study Drug · 14 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03675893Phase 2 · recruiting RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer · 14 trials list this drug (3 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · 14 trials list this drug (3 active) | — | — | Hepatoblastoma,Malignant Germ Cell Tumor,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057133Phase 1 · active not recruiting A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread · 14 trials list this drug (3 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02784795Phase 1 · terminated A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors · 14 trials list this drug (3 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Soft Tissue Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02549989Phase 2 · completed Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer · 14 trials list this drug (3 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01655225Phase 1 · completed A Study of LY3023414 in Participants With Advanced Cancer · 14 trials list this drug (3 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm,Malignant Mesothelioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407054Phase 2 · completed A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer · 14 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02443337Phase 2 · terminated A Study of LY3023414 and Necitumumab in Squamous Lung Cancer · 14 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02079636Phase 1 · completed A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC) · 14 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02124148Phase 1 · completed A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer · 14 trials list this drug (3 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02981342Phase 2 · completed A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma · 14 trials list this drug (3 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02536586Phase 1 · completed A Study of LY3023414 in Japanese Participants With Advanced Cancer · 14 trials list this drug (3 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |